BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21570286)

  • 1. New light labile linker for solid phase synthesis of 2'-O-acetalester oligonucleotides and applications to siRNA prodrug development.
    Johnsson R; Lackey JG; Bogojeski JJ; Damha MJ
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3721-5. PubMed ID: 21570286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple solid-phase synthesis and biological properties of carbohydrate-oligonucleotide conjugates modified at the 3'-terminus.
    Ikeda Y; Kubota D; Nagasaki Y
    Bioconjug Chem; 2010 Sep; 21(9):1685-90. PubMed ID: 20704260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A whole base-labile strategy for RNA synthesis with 2'-O-acetalester protections.
    Lavergne T; Martin A; Debart F; Vasseur JJ
    Nucleic Acids Symp Ser (Oxf); 2008; (52):51-2. PubMed ID: 18776248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct synthesis of partially modified 2'-O-pivaloyloxymethyl RNAs by a base-labile protecting group strategy and their potential for prodrug-based gene-silencing applications.
    Biscans A; Bos M; Martin AR; Ader N; Sczakiel G; Vasseur JJ; Dupouy C; Debart F
    Chembiochem; 2014 Dec; 15(18):2674-9. PubMed ID: 25346406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of oligonucleotides carrying amino lipid groups at the 3'-end for RNA interference studies.
    Grijalvo S; Ocampo SM; Perales JC; Eritja R
    J Org Chem; 2010 Oct; 75(20):6806-13. PubMed ID: 20863084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of light-responsive bridged nucleic acid and changes in affinity with complementary ssRNA.
    Morihiro K; Kodama T; Nishida M; Imanishi T; Obika S
    Chembiochem; 2009 Jul; 10(11):1784-8. PubMed ID: 19575376
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of oligonucleotides containing 3'-alkylcarboxylic acids using a palladium labile oligonucleotide solid phase synthesis support.
    Matray TJ; Yoo DJ; McMinn DL; Greenberg MM
    Bioconjug Chem; 1997; 8(2):99-102. PubMed ID: 9095347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary evaluation of pro-RNA 2'-O-masked with biolabile pivaloyloxymethyl groups in an RNA interference assay.
    Lavergne T; Baraguey C; Dupouy C; Parey N; Wuensche W; Sczakiel G; Vasseur JJ; Debart F
    J Org Chem; 2011 Jul; 76(14):5719-31. PubMed ID: 21619027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide charge reversal: 2'-O-lysylaminohexyl modified oligonucleotides.
    Winkler J; Noe CR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):939-42. PubMed ID: 18058513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial photorelease of oligonucleotides, using a safety-catch photolabile linker.
    Flickinger ST; Patel M; Binkowski BF; Lowe AM; Li MH; Kim C; Cerrina F; Belshaw PJ
    Org Lett; 2006 May; 8(11):2357-60. PubMed ID: 16706525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of oligonucleotide prodrugs bearing N-acetyl nucleobases.
    Brès JC; Imbach JL; Morvan F
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1243-5. PubMed ID: 14565390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatically Cleavable siRNA Prodrugs: a New Paradigm for the Intracellular Delivery of RNA-Based Therapeutics.
    Ducho C
    ChemMedChem; 2015 Oct; 10(10):1625-7. PubMed ID: 26387983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycomimetics as decorating motifs for oligonucleotides: solid-phase synthesis, stability, and hybridization properties of carbopeptoid-oligonucleotide conjugates.
    D'Onofrio J; de Champdoré M; De Napoli L; Montesarchio D; Di Fabio G
    Bioconjug Chem; 2005; 16(5):1299-309. PubMed ID: 16173811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA oligonucleotide synthesis via 5'-silyl-2'-orthoester chemistry.
    Scaringe SA
    Methods; 2001 Mar; 23(3):206-17. PubMed ID: 11243834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase synthesis of siRNA oligonucleotides.
    Beaucage SL
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):203-16. PubMed ID: 18283608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide synthesis involving deprotection of amidine-type protecting groups for nucleobases under acidic conditions.
    Ohkubo A; Kuwayama Y; Nishino Y; Tsunoda H; Seio K; Sekine M
    Org Lett; 2010 Jun; 12(11):2496-9. PubMed ID: 20455549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to the synthesis of natural and modified oligonucleotides by the phosphotriester method using O-nucleophilic intramolecular catalysis.
    Efimov VA; Molchanova NS; Chakhmakhcheva OG
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1087-93. PubMed ID: 18058542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted 2-nitrobenzyltrichloroacetate esters for photodirected oligonucleotide detritylation in solid films.
    Serafinowski PJ; Garland PB
    Org Biomol Chem; 2008 Sep; 6(18):3284-91. PubMed ID: 18802634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new route to 2'-O-alkyl-2-thiouridine derivatives via 4-O-protection of the uracil base and hybridization properties of oligonucleotides incorporating these modified nucleoside derivatives.
    Okamoto I; Shohda K; Seio K; Sekine M
    J Org Chem; 2003 Dec; 68(26):9971-82. PubMed ID: 14682690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in oligonucleotide synthesis.
    Pfleiderer W; Matysiak S; Bergmann F; Schnell R
    Acta Biochim Pol; 1996; 43(1):37-44. PubMed ID: 8790710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.